We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Provides Insights into Abdominal Aortic Aneurysms

By MedImaging International staff writers
Posted on 28 Oct 2014
Print article
Image: Purdue University researchers are using ultrasound images like this one to study abdominal aortic aneurysms, a potentially fatal condition that is the 13th leading cause of death in the United States (Photo courtesy of Purdue University/Weldon School of Biomedical Engineering).
Image: Purdue University researchers are using ultrasound images like this one to study abdominal aortic aneurysms, a potentially fatal condition that is the 13th leading cause of death in the United States (Photo courtesy of Purdue University/Weldon School of Biomedical Engineering).
Researchers are assessing the effectiveness of the use of ultrasound to study lethal abdominal aortic aneurysms (AAAs), a bulging of the aorta that is typically fatal when it ruptures, and for which there is no effective medical treatment.

Abdominal aortic aneurysms are the 13th leading cause of death in the United States, killing about 15,000 yearly. “Most of the time people don’t even know it’s there, but if it does rupture they have internal bleeding from the largest artery in the body,” said Craig Goergen, an assistant professor in Purdue University’s (West Lafayette, IN, USA) Weldon School of Biomedical Engineering. “Eighty percent of the time the patient dies before getting to the hospital.”

Researchers have used a technique called high-frequency small animal ultrasound to measure alterations in the progression of abdominal aortic aneurysms in lab animals. By learning more about aneurysms at the molecular level, researchers might be able to develop drug or stem cell therapies to keep them from growing larger, according to Dr. Goergen.

New findings were presented on October 25, 2014, by doctoral student Evan Phillips during the Biomedical Engineering Society’s annual meeting in San Antonio (TX, USA). The researchers are able to monitor small changes in the vessel as the aneurysm forms. Ultrasound imaging allows for visualization of the arterial layers that frequently separate from each other while the vessel grows. “The development of these aneurysms is a multifaceted process that has not been fully characterized, and no therapeutics have proven to effectively prevent aneurysm progression,” Dr. Goergen said. “What we want to do is understand what causes aneurysms to form and grow so that we can then develop better strategies to prevent that from happening.”

The ultrasound technique also uses color Doppler imaging, making it possible for researchers to collect color-coded blood flow data showing the direction and speed of circulation, both of which are factors that might influence how aneurysms develop and expand. The frequency of a wave changes as it moves toward or away from the observer, a phenomenon known as the Doppler effect. Color Doppler images reveal red flow moving toward the ultrasound transducer and blue flow moving away. The efforts are laying a basis for additional studies that might use these strategies in a clinical setting or to investigate potential therapeutics, according to Dr. Goergen.

Human aortic aneurysms typically begin at 3–4 cm in diameter and are located in the abdomen below the kidneys. The aorta extends from the heart through the body and ultimately branches into two smaller arteries leading to the legs. Most at risk are older men who have high blood pressure and a history of smoking. Men over 65 who fit this profile are advised to contact their doctor about ultrasound screening to determine if they have an aneurysm.

“Unless you feel a pulsating mass, develop unusual back pain, or are screened with ultrasound, most people don’t even discover that they have it. If you are diagnosed, most surgeons won’t treat aneurysms less than 4 cm. Unfortunately, there is no medicine that can prevent aneurysms from growing,” Dr. Goergen said. “Doctors can give you statins to lower your cholesterol levels or anti-hypertension medication to lower your blood pressure, but there are no medications that can directly prevent aneurysm expansion.”

However, researchers can analyze laboratory animals that mimic conditions in humans to provide insights into the mechanisms behind aneurysms. The group led by Dr. Goergen used ultrasound imaging to quantify changes over a four-week period as aneurysms developed and expanded in mice and rats. “We’re doing three-dimensional ultrasound that can reconstruct that whole aorta,” Dr. Goergen said.

Because this technique is noninvasive, it may ultimately be used on humans to diagnose and monitor aneurysm progression.

Related Links:

Purdue University


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Thyroid Shield
Standard Thyroid Shield
New
Color Doppler Ultrasound System
DRE Crystal 4PX
X-Ray Meter
Cobia SENSE

Print article

Channels

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.